China advances brain-computer interface technology as trials grow
Synopsis
China is expanding brain-computer interface (BCI) research and clinical trials as part of its broader push into advanced neurotechnology. Scientists say some brain-computer interface (BCI) applications could reach wider public use within three to five years. With increasing government support, medical research and global investment, the brain-computer interface (BCI) sector is emerging as a key area of innovation in healthcare and digital technology.
China is accelerating brain-computer interface (BCI) research with expanding clinical trials and national policy support. Experts say some brain-computer interface (BCI) applications could reach wider public use within three to five years as global investment in neurotechnology continues to grow.
Key Highlights
- China could see broader brain-computer interface use within three to five years, according to experts.
- More than ten human clinical trials of invasive BCI implants are underway in China.
- Government strategy targets key brain-computer interface breakthroughs by 2027.
- Global brain-computer interface market projected to exceed $8 billion by 2033.
China is accelerating the development of brain-computer interface (BCI) technology, with experts suggesting broader adoption could occur within the next three to five years as research advances and clinical trials expand.
A brain-computer interface (BCI) enables direct communication between the human brain and external devices by translating neural signals into digital commands. The technology is primarily being developed to help people with neurological conditions, including paralysis, control computers, prosthetic limbs or other assistive devices.
Growing research activity indicates that brain-computer interface (BCI) technology is moving closer to practical medical applications.
Clinical trials advance brain-computer interface technology
Yao Dezhong, director of the Sichuan Institute of Brain Science, said progress in brain-computer interface (BCI) research and product development could allow certain applications to reach wider public use in China within three to five years.
China currently has more than ten human clinical trials involving invasive brain-computer interface (BCI) implants. Authorities are also planning to enrol at least 50 additional patients in 2026 as part of expanded testing.
Researchers are working on several types of brain-computer interface (BCI) systems, including:
- Invasive BCI implants are placed directly inside the brain
- Semi-invasive BCI devices positioned on the brain’s surface
- Non-invasive BCI technologies that detect brain signals externally through sensors.
Early trials have already allowed some patients with paralysis to control computer cursors or operate digital interfaces using brain-computer interface (BCI) technology.
Government strategy supports neurotechnology development
China has identified brain-computer interface (BCI) systems as a strategic emerging technology in national development plans, alongside fields such as artificial intelligence, quantum computing and advanced communications.
Under a national roadmap, the country aims to achieve key technological breakthroughs in brain-computer interface (BCI) development by 2027 and create two to three globally competitive companies in the sector by 2030.
Authorities have also begun including certain brain-computer interface (BCI) treatments in pilot public medical insurance programmes in some regions, a move designed to support clinical adoption.
Hospitals and research institutions across China have established specialised laboratories dedicated to brain-computer interface (BCI) research and testing.
Global competition grows in brain-computer interface sector
China’s push into brain-computer interface (BCI) technology comes as several countries increase investment in neurotechnology.
The United States remains a major centre for brain-computer interface (BCI) innovation, where companies such as Neuralink, founded by Elon Musk, are conducting human trials involving implantable brain chips designed to assist patients with severe neurological conditions.
Research teams in Germany, Japan and South Korea are also advancing brain-computer interface (BCI) systems, particularly in rehabilitation technologies and non-invasive brain signal monitoring.
Industry estimates indicate that the global brain-computer interface (BCI) market was valued at about $2 billion in 2024 and could exceed $8 billion by 2033.
China’s domestic brain-computer interface (BCI) market was estimated at approximately 3.2 billion yuan ($440 million) in 2024 and could reach 5.58 billion yuan (around $800 million) by 2027, reflecting rising investment and growing medical demand.
Researchers say China’s large patient population and expanding medical research infrastructure could further accelerate the development and adoption of brain-computer interface (BCI) technology.
FAQs
Q1. What is a brain-computer interface (BCI)?
A brain-computer interface (BCI) is a system that converts brain signals into digital commands, allowing people to control computers, devices or prosthetics using brain activity.
Q2. When could brain-computer interface technology become widely used in China?
Experts say some brain-computer interface (BCI) applications could see broader use within three to five years as clinical trials expand.
Q3. Which countries are leading brain-computer interface research?
Major brain-computer interface (BCI) research is taking place in the United States, China, Germany, Japan and South Korea.
Follow Inspirepreneur Magazine for the business news.
Pooja Malik is a business journalist with over six years of experience covering startups, entrepreneurship, and emerging trends. She has previously worked with leading media platforms such as YourStory Media and BW BusinessWorld, where she reported on business, policy, and market developments. Currently, she serves as Editor at The Inspirepreneur Magazine, where she writes and edits stories across business, lifestyle, and travel, with a focus on clarity, accuracy, and reader relevance.
